Skip to content
VC FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 9 SOURCES

Unirisco

Also known as Unirisco Galicia, S.C.R., S.A.

Galician venture capital company owned by the three Galician universities and regional companies; minority pre-seed and seed stakes in university spin-offs since 2001.

HEADQUARTERS
Santiago de Compostela, Spain
FOUNDED
1998
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
3 people

Focus

STAGES
Pre-SeedSeed
ASSET MIX
Venture capitalImpact
GEOGRAPHY
Spain

Overview

Unirisco Galicia is a private venture capital company (SCR) promoted by the universities of Santiago de Compostela, A Coruña and Vigo together with Galician companies including Abanca, Inditex, Constructora San José, Estrella de Galicia, Gadisa, R Cable and Pescamar, plus Banco Santander. It takes temporary minority stakes in science- and technology-based spin-offs from Galician universities and research centres at pre-seed and seed stage, and says it has worked with more than 30 companies since 2001. Recent investments include Gazella Biotech (2024), Néboda (2025) and Batea Oncology (2025).

Investment thesis

Temporary minority investments in spin-offs born in the Galician university, technology and R&D ecosystem, at pre-seed and seed, under social-impact and return criteria.

PORTFOLIO (9)

  • Batea Oncology
    HealthTech · since 2025
  • Néboda
    Food & Agriculture · since 2025
  • Gazella Biotech
    Biotech & Life Sciences · since 2024
  • Diversa Technologies
    Biotech & Life Sciences
  • InVerbis
    Artificial Intelligence
  • Oncostellae
    Biotech & Life Sciences
  • Situm
    Software & SaaS
  • Tastelab
    Food & Agriculture
  • Appentra
    Software & SaaS

People

  • Inmaculada Rodríguez Cuervo
    Managing Director (Directora general) · source
  • Pablo Mosquera Martínez
    Investment Director · source
  • Paulo González Alonso
    Investment Analyst · source

Links

Frequently asked questions

Unirisco is a VC fund based in Santiago de Compostela, Spain, founded in 1998.

Yes. Unirisco invests its own capital in private companies.

Unirisco invests at Pre-Seed and Seed stages in Biotech & Life Sciences, HealthTech, Software & SaaS and Food & Agriculture.

Key people at Unirisco include Inmaculada Rodríguez Cuervo (Managing Director (Directora general)), Pablo Mosquera Martínez (Investment Director) and Paulo González Alonso (Investment Analyst).

Unirisco's investments include Batea Oncology, Néboda, Gazella Biotech, Diversa Technologies, InVerbis, Oncostellae, Situm and Tastelab, among others.

The most recent publicly reported investment by Unirisco is Batea Oncology (Financing round with Xesgalicia), announced in Sep 2025.

Yes. Unirisco manages capital from outside investors.